(Q35671648)

9 August 2017

1 reference

title

Serious adverse events following treatment with ivermectin for onchocerciasis control: a review of reported cases (English)

1 reference

9 August 2017

0 references

0 references

Nana AY Twum-Danso

1

1 reference

9 August 2017

publication date

1 January 2003

1 reference

9 August 2017

published in

Parasites and Vectors

1 reference

9 August 2017

volume

2 Suppl 1

1 reference

9 August 2017

page(s)

S3

1 reference

https://scigraph.springernature.com/pub.10.1186/1475-2883-2-s1-s3

9 August 2017

exact match

0 references

cites work

Prevalences of Loa loa microfilaraemia throughout the area endemic for the infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2147655

Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2147655

Secondary effects of the treatment of hypermicrofilaremic loiasis using ivermectin

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2147655

The chemotherapy of onchocerciasis X. An assessment of four single dose treatment regimes of MK-933 (ivermectin) in human onchocerciasis.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2147655

Adverse reactions after large-scale treatment of onchocerciasis with ivermectin: combined results from eight community trials

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2147655

Ivermectin. A review of its antifilarial activity, pharmacokinetic properties and clinical efficacy in onchocerciasis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2147655

Relationships between the prevalence and intensity of Loa loa infection in the Central province of Cameroon

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2147655

Satellite mapping of Loa loa prevalence in relation to ivermectin use in west and central Africa

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2147655

Marked decrease in Loa loa microfilaraemia six and twelve months after a single dose of ivermectin.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2147655

Reduced Loa loa microfilaria count ten to twelve months after a single dose of ivermectin.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2147655

Severe adverse reaction risks during mass treatment with ivermectin in loiasis-endemic areas

25 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/14975060

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1475-2883-2-S1-S3

1 reference

Dimensions Publication ID

9 August 2017

0 references

1 reference

9 August 2017

1 reference